Delivery Order SPE2DR25D1109-SPE2DR26FFG4D
- Not listed
- The Defense Logistics Agency awarded a $2,615.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for Belbuca 900 microgram films (60-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-competitive, non-set-aside award represents a small-value transaction typical of routine pharmaceutical supply replenishment. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $1,301.11 delivery order to AmerisourceBergen Drug Corp for the supply of Belbuca 900 mcg film (60 count) under a firm fixed price contract. The order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Belbuca 600 mcg film (60 count) with a ceiling value of $1,123.96. This firm fixed price delivery order represents a non-competitive, non-set-aside award and is set for ultimate completion by October 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $3,635.46 by the Defense Logistics Agency on June 13, 2025, with an ultimate completion date of June 16, 2025. The contract, which carries no set-aside designation, calls for the delivery of Belbuca 300 microgram film (60 count), a buccal film formulation used for pain management. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,455.48 delivery order to AmerisourceBergen Drug Corp for BELBUCA 750 microgram film (60 count) on September 19, 2025, with completion targeted for September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with...
- The Defense Logistics Agency awarded a $1,168.12 delivery order to AmerisourceBergen Drug Corp for BELBUCA 750 MCG film (60 count) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively granted with no...
- The Defense Logistics Agency awarded a delivery order valued at $2,045.41 to AmerisourceBergen Drug Corp for 60 units of Belbuca 600 microgram film on November 5, 2025, with completion scheduled for November 6, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.52 to AmerisourceBergen Drug Corp for BELBUCA 300 MCG Film (60 count) on July 25, 2025, with completion expected by July 28, 2025. This is a firm fixed price, non-set-aside contract executed as a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The product is a buccal film formulation used for pain management, reflecting the company's role as a critical pharmaceutical distributor for...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on June 18, 2025, for BELBUCA 900 MCG Film in a quantity of 60 units, with a ceiling value of $1,127.25. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. Performance will take place at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Belbuca 600 microgram films (60 count). This competitively awarded, non-set-aside delivery order carries a ceiling value of $2,683.50 with firm fixed pricing and an ultimate completion date of October 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFG4DDelivery Order
The Defense Logistics Agency awarded a $2,693.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 units of Belbuca 300 mcg film on November 13, 2025, with completion expected by November 14, 2025. This non-set-aside award represents a pharmaceutical supply delivery to support federal medical procurement needs. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and other critical medical commodities. The contract demonstrates AmerisourceBergen's capability to fulfill federal medical supply requirements through competitive procurement processes, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 11/13/25 |